Vegan Cheese Brand Daiya Foods Acquired for $325 Million, Buyout Sparks Controversy Over Animal Testing

daiya foods
Image via Daiya Foods

Canadian plant-based food company Daiya Foods has been acquired by Japanese pharmaceutical company Otsuka for CA$405 million ($325.97 million). Otsuka sells several products in North America including the Nature Made brand of vitamins.

The acquisition is expected to “help increase Daiya’s presence throughout North America and beyond,” according to a statement from the companies.

“With aligned values and vision, Daiya and Otsuka have a tremendous opportunity to bring the incredible benefits of a plant-forward lifestyle to people around the world,” Terry Tierney, Daiya’s CEO, says in the statement.

The entire senior leadership team at Daiya, including founders Greg Blake and Andre Kroecher, will be staying on following the acquisition.

Daiya got its start making plant-based cheese products, but the company now produces 30 plant-based products including cheesecake and Greek yogurt. It is one of the founding members of The Plant Based Foods Association, a trade association representing 75 of the leading American plant-based food businesses.

Daiya was founded in Vancouver, Canada in 2008, but it has since expanded into the U.S. market and derives most of its revenue from the United States, according to a release from Otsuka. The company tripled its sales in the last three years, showing an enormous potential for future growth following the acquisition.

“It’s become clear from the recent growth of the country – that’s been nothing short of extraordinary – that we now have a much much bigger opportunity to play a leadership role in the plant-based food movement,” Tierney told FoodNavigator-USA. “And in order for us to really fulfill our destiny, we needed all the right resources available to us – not just money, but intellectual capital, wisdom, experience, and the ability to expand the brand across the globe.”

Just days after the announcement, the company came under fire via a petition started by “Keep Veganism Vegan” criticizing the deal given Otsuka’s position on animal testing.

“Otsuka is a known pharmaceutical and nutraceutical company that uses animals in it laboratory testing, as well as in it’s research and development,” reads the petition. “What Daiya has now shown us is that anyone can be bought; they too had a price point where the torture and suffering of animals is acceptable, so long as they stand to make much more money for themselves.”

According to Food Dive, this acquisition represents a larger trend of pharmaceutical companies turning to the nutrition sector for investment opportunities.

“Apart from increased global reach, the deal is likely to give Daiya access to Otsuka’s expertise and more advanced pharmaceutical-grade equipment, which is becoming more common in the plant-based food industry,” reports Food Dive. “Plant-based condiments and sweets company Hampton Creek has told Food Dive uses pharma-grade equipment to improve the structure and nutrition of its products.”

The plant-based foods sector has shown enormous potential in recent years, topping $5 billion in sales in March, according to data from SPINS, the leading retail sales data company for natural and specialty products. Plant-based milk sales topped $4.2 billion over the past year, but cheese alternatives proved to be the fastest growing category, with 18 percent growth.

Related on Organic Authority
Will Hospitals Ban Meat? AMA Emphasizes the Plant-Based Diet
More Plant-Based Foods Coming to Supermarkets with Launch of Retail-Focused Fund
Canadian Officials Encourage the Country to Shift to a Plant-Based Whole Foods Diet

Emily Monaco
Emily Monaco

Emily Monaco is an American food and culture writer based in Paris. She loves uncovering the stories behind ingredients and exposing the face of our food system, so that consumers can make educated choices. Her work has been published in the Wall Street Journal, Vice Munchies, and Serious Eats.